© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Interpace Biosciences, Inc. (IDXG) shows an Average True Range (ATR) of N/A and an Enterprise Value of N/A. Its average trading volume over the past 3 months is N/A, indicating liquidity. These fundamental metrics provide insight into IDXG's underlying financial health and market activity.
| ATR | N/A |
| Enterprise Value | - |
| Avg Vol (3 Months) | - |
| Avg Vol (10 Days) | - |
Interpace Biosciences, Inc. (IDXG) technical indicators as of July 29, 2026: the SMA 20 is N/A, SMA 50 at N/A, and SMA 200 at N/A. The RSI 14 value is N/A, suggesting its current momentum. These technical analysis signals help assess IDXG's price trends and potential future movements.
| SMA 20 | N/A |
| SMA 50 | N/A |
| SMA 200 | N/A |
| RSI 14 | N/A |
Interpace Biosciences, Inc. (IDXG) stock performance overview as of July 29, 2026: The 52-week high is $2.4 (currently N/A below), and the 52-week low is $0.77 (currently N/A above). Over the past year, IDXG's performance is N/A, compared to the S&P 500's 3.36% change.
| 52-Week High | 2.4 |
| 52-Week High Chg | - |
| 52-Week Low | 0.77 |
| 52-Week Low Chg | - |
| S&P 500 52-Week Chg | 3.36% |
According to market data, Interpace Biosciences, Inc. (IDXG) stock's recent performance metrics show that over the last month, IDXG is N/A, with a Year-to-Date (YTD) performance of N/A. Over the past year, the stock has seen a N/A change. These figures summarize IDXG's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 1.55 | 1.8 | 2.14 | 2.4 | 2.4 | 2.4 |
| Low | 1.34 | 1.34 | 1.34 | 1.05 | 0.77 | 1.05 |
| Performance | - | - | - | - | - | - |
According to current financial data, IDXG stock's P/E (TTM) ratio is 0.29, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -0.97. Key valuation ratios for IDXG, including P/S (1.15), P/B (1.49), and P/FCF (9.55), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | IDXG | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | 0.29 | -0.97 | 25.95 | 32.59 |
| P/S (TTM) | 1.15 | 3.06 | 28.95 | 5.98 |
| P/B (TTM) | 1.49 | 9.81 | -3.66 | 5.59 |
| P/FCF (TTM) | 9.55 | -3.65 | -3.54 | 31.65 |